Related references
Note: Only part of the references are listed.Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in cryptococcosis
Megumi Nishitani Yukuyama et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2021)
In vivo synergism of free miltefosine or in alginate-based nanocarrier combined with voriconazole on aspergillosis
Thayna L. Barreto et al.
FUTURE MICROBIOLOGY (2021)
Polysorbate-Based Drug Formulations for Brain-Targeted Drug Delivery and Anticancer Therapy
Vasanthan Ravichandran et al.
APPLIED SCIENCES-BASEL (2021)
Cryptococcal meningoencephalitis: time for action
Katharine Elizabeth Stott et al.
LANCET INFECTIOUS DISEASES (2021)
17-β-Estradiol increases macrophage activity through activation of the G-protein-coupled estrogen receptor and improves the response of female mice to Cryptococcus gattii
Marliete C. Costa et al.
CELLULAR MICROBIOLOGY (2020)
Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis
Fernanda Walt Mendes da Silva de Bastiani et al.
FRONTIERS IN MICROBIOLOGY (2020)
New Approaches for Cryptococcosis Treatment
Cristina de Castro Spadari et al.
MICROORGANISMS (2020)
Nanocarriers as Potential Drug Delivery Candidates for Overcoming the Blood-Brain Barrier: Challenges and Possibilities
Jyoti Ahlawat et al.
ACS OMEGA (2020)
Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris
Thayna Lopes Barreto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Antifungal drugs: An updated review of central nervous system pharmacokinetics
Fernanda Wirth et al.
MYCOSES (2020)
Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis
Cristina de Castro Spadari et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts
Cristina de Castro Spadari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vitro Activities of Miltefosine and Antibacterial Agents from the Macrolide, Oxazolidinone, and Pleuromutilin Classes against Pythium insidiosum and Pythium aphanidermatum
Erico S. Loreto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Effect of Surfactant Coating on Brain Targeting Polymeric Nanoparticles; a Review
B. J. Chacko et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis
Keerthi G. S. Nair et al.
INFLAMMOPHARMACOLOGY (2018)
Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most
Temmy Sunyoto et al.
BMJ GLOBAL HEALTH (2018)
Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation
Diego Conrado Pereira Rossi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Radha Rajasingham et al.
LANCET INFECTIOUS DISEASES (2017)
Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment
Johanna K. Valenzuela-Oses et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Cryptococcus: from environmental saprophyte to global pathogen
Robin C. May et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Miltefosine-loaded lipid nanoparticles: Improving miltefosine stability and reducing its hemolytic potential toward erythtocytes and its cytotoxic effect on macrophages
Jose Jardes da Gama Bitencourt et al.
BIOPHYSICAL CHEMISTRY (2016)
Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of Paracoccidioidomycosis
Camila Arruda Saldanha et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy
Tessa Rui Min Tan et al.
PLOS ONE (2016)
Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole
Luana Pereira Borba-Santos et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2015)
In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
Fabrice Compain et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain
Sharon L. Roy et al.
PARASITOLOGY RESEARCH (2015)
Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study
Maha M. Eissa et al.
PLOS ONE (2015)
In Vitro Combination of Voriconazole and Miltefosine against Clinically Relevant Molds
S. Imbert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In vitro inhibitory effect of miltefosine against strains of Histoplasma capsulatum var. capsulatum and Sporothrix spp.
Raimunda Samia Nogueira Brilhante et al.
MEDICAL MYCOLOGY (2014)
Limited Activity of Miltefosine in Murine Models of Cryptococcal Meningoencephalitis and Disseminated Cryptococcosis
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Novel microparticulate systems for the vaginal delivery of nystatin: Development and characterization
M. J. Martin-Villena et al.
CARBOHYDRATE POLYMERS (2013)
The Role of Host Gender in the Pathogenesis of Cryptococcus neoformans Infections
Erin E. McClelland et al.
PLOS ONE (2013)
Nanoparticulate systems for brain delivery of drugs
Joerg Kreuter
ADVANCED DRUG DELIVERY REVIEWS (2012)
Characterization and identification of suspected counterfeit miltefosine capsules
Thomas P. C. Dorlo et al.
ANALYST (2012)
The Cryptococcus neoformans Capsule: a Sword and a Shield
Teresa R. O'Meara et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice
Nan Xu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Biopolymeric nanoparticles
Sushmitha Sundar et al.
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2010)
Immortalized Human Brain Endothelial Cell Line HCMEC/D3 as a Model of the Blood-Brain Barrier Facilitates In Vitro Studies of Central Nervous System Infection by Cryptococcus neoformans
Kiem Vu et al.
EUKARYOTIC CELL (2009)
Preparation and Therapeutic Efficacy of Polysorbate-80-Coated Amphotericin B/PLA-b-PEG Nanoparticles
Tianbin Ren et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2009)
In vitro activities of miltefosine and two novel antifungal biscationic salts against a panel of 77 dermatophytes
Zhongsheng Tong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Hexadecylphosphocholine (Miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis
F Widmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain
WQ Sun et al.
BIOMATERIALS (2004)
Share Paper
